First AD

Second AD

Melanoma & Skin Cancer

The OncLive Melanoma & Skin Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of skin cancers, including melanoma, basal cell carcinoma, and more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in melanoma and other skin cancers.

My Treatment Approach: Metastatic Melanoma

Insights

Experts discuss the use of BRAF and MEK inhibitors as first-line treatments for patients with metastatic melanoma.

First-line Treatment Strategies for BRAF-Mutant Metastatic Melanoma: BRAF/MEK Inhibitors

The Current State of Metastatic Melanoma

First-line and Subsequent Treatment Strategies for Unresectable/Metastatic Melanoma: A Patient Profile

First-line Treatment Strategies for BRAF-Mutant Metastatic Melanoma: Ipilimumab & Nivolumab

First-line Treatment Strategies for BRAF-Mutant Metastatic Melanoma: Unmet Needs

Frontline Trials for BRAF-Mutant Metastatic Melanoma: Relatlimab Plus Nivolumab

Second-line Treatment Strategies for BRAF-mutant Metastatic Melanoma: Patient Profile Revisited

Second-line Treatment Strategies for BRAF-mutant Metastatic Melanoma: Additional Patient Scenarios

Closing Remarks on the Treatment of Patients With Metastatic Melanoma